2 weeks Ago By Defense World Staff
Equities research analysts at StockNews.com began coverage on shares of Bellerophon Therapeutics ( NASDAQ:BLPH – Get Free Report ) in a report released on Sunday. The firm set a “hold” rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance NASDAQ:BLPH opened at $0.04 on Friday. The stock has a 50-day moving average price of $0.
04 and a 200 day moving average price of $0.05. The stock has a market capitalization of $440,388.
00, a P/E ratio of -0.04 and a beta of 0.70.
Bellerophon Therapeutics has a 12-month low of $0.03 and a 12-month high of $0.42.
Bellerophon Therapeutics Company Profile ( Get Free Report ) Further Reading Five stocks we like better than Bellerophon Therapeutics 3 Warren Buffett Stocks to Buy Now CarMax’s Impressive Rally: What Investors Should Watch Next The Top 3 Healthcare Dividend Stocks to Buy and Hold MarketBeat Week in Review – 9/23 – 9/27 Health Care Stocks Explained: Why You Might Want to Invest Wake Up to This Biotech Stock That Still Has Big Potential Upside Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter ..
